About this trial
The purpose of this study is to develop biocompatible wireless electronic devices that will allow continuous, non-invasive hemodynamic and physiology measurements in the ICU.
Eligibility criteria
This trial accepts healthy volunteersQualifiers
Admitted to one of the four ICUs at Lurie Children's or Prentice Women's Hospital
Under 18 years of age
Under 18 years of age
Willing to visit the Center for Autonomic Medicine in Pediatrics (CAMP) for a one time study visit
Disqualifiers
A skin abnormality that would potentially increase the risk of device
18 years of age or older
Determined by an attending physician or bedside care team to be too unstable (patient) or experiencing too much stress (family)
A skin abnormality that would potentially increase risk of device use
Trial population
Patients admitted to one of 3 ICUs at Lurie Children's, or healthy volunteers visiting CAMP at Lurie Children's
Trial design
Cohort
Prospective
Treatments tested in this trial
Wireless Wearable Vital Sign Monitor
DevicePlacement of wireless wearable vital sign monitors on patients limbs for up to 48 hours
Treatment groups
Trial outcomes
Primary outcomes
Continuous non-invasive BP monitoring
Recorded measurements of BP as compared to the ICU standard of care monitoring, including both arterial line measurements and cuff-based measurements of the arm (mm Hg).
Secondary outcomes
Accuracy of Other Physiologic Signals
correlation of vital signs to current technology used on the units: heart rate (beats/min); respiratory rate (breaths/min); temperature (degrees Celsius); oxygen saturation (SpO2, %)
Sponsors and contacts
Click on the lead sponsor to view all of their trials.